Anaplastic multiple myeloma: possible limitations of conventional chemotherapy for long-term remission

Letter to the editor

Author information

Satoshi Ichikawa Corresponding author
Department of Hematology and Rheumatology, Tohoku University Hospital, Sendai, Japan,
Noriko Fukuhara
Department of Hematology and Rheumatology, Tohoku University Hospital, Sendai, Japan,
Shunsuke Hatta
Department of Hematology and Rheumatology, Tohoku University Hospital, Sendai, Japan,
Masahito Himuro
Department of Hematology and Rheumatology, Tohoku University Hospital, Sendai, Japan,
Kentaro Nasu
Department of Hematology and Rheumatology, Tohoku University Hospital, Sendai, Japan,
Koya Ono
Department of Hematology and Rheumatology, Tohoku University Hospital, Sendai, Japan,
Yoko Okitsu
Department of Hematology and Rheumatology, Tohoku University Hospital, Sendai, Japan,
Masahiro Kobayashi
Department of Hematology and Rheumatology, Tohoku University Hospital, Sendai, Japan,
Yasushi Onishi
Department of Hematology and Rheumatology, Tohoku University Hospital, Sendai, Japan,
Masaki Ri
Department of Hematology and Oncology, Nagoya City University Hospital, Nagoya, Japan,
Ryo Ichinohasama
Department of Hematopathology, Tohoku University Graduate School of Medicine, Sendai, Japan
Hideo Harigae
Department of Hematology and Rheumatology, Tohoku University Hospital, Sendai, Japan,

JOURNAL FREE ACCESS

2018 Volume 58 Issue 1 Pages 39-42

Details